The following awards are presented annually at the Society for Melanoma Research Congress.
This award is presented to an individual who has made major and impactful contributions to melanoma research throughout their career.
2018 - Neal Rosen, MD, PhD
2017 - Julia Newton Bishop, PhD
2016 - Ze’ev Ronai, PhD
2015 - James P. Allison, PhD
2014 - Boris C. Bastian, MD, PhD
2013 - Glenn Merlino, PhD
2012 - Nicholas K. Hayward, PhD
2011 - David Fisher, MD
2010 - Meenhard Herlyn, DVM, DSc
2009 - Ruth Halaban, MD
This award was established in 2010 in memory of Estela Medrano. Estela was a leader in the study of TGFb-related signaling in melanoma as well as senescence. She was also an active participant in SMR activities and was about to become the new secretary/treasurer for SMR. Estela was tragically killed in an automobile accident in August 2010. Although originally given to the keynote lecturer at the Society for Melanoma Research annual international congress, in 2013, an ad hoc review committee recommended that specific consideration be given to a woman who has made major contributions in the fight against melanoma to fully honor Estela's memory.
2018 - Caroline Robert, MD, PhD
2017 - Marisol Soengas, PhD
2016 - Sancy Leachman, MD, PhD
2015 - Suzanne Topalian, MD
2014 - Lynda Chin, MD
2013 - Dorothy Bennett, PhD
2012 - Michael Stratton, MD, PhD
2011 - Richard Marais, PhD
2010 - Keith T. Flaherty, MD
Now sponsored by the Melanoma Research Foundation this award is presented to an individual who is an independent researcher, in the junior stage (typically within first 5 years) of their career and who has made contributions in the area of melanoma research that significantly exceed the average for this career stage.
2018 - A. Hunter Shain, PhD
2017 - Richard White, MD, PhD
2016 - Poulikos Poulikakos, PhD
2015 - Georgina Long, BSc, PhD, MBBS, FRACP
2014 - Jennifer A. Wargo, MD, MMSc
2013 - Roger Lo, MD, PhD
2006 - Pam Pollock and Ashani Weeraratna
Established in 2013 this award is presented to an individual or group for highly impactful, major discoveries in the field of melanoma within the last 5 years.
2018 - Jennifer Wargo, MD, MMSc
2017 - Richard Marais, PhD
2016 - Marisol Soengas, PhD
2015 - Daniel Peeper, PhD
2014 - Levi A. Garraway, MD, PhD
2013 - Antoni Ribas, MD, PhD
For Studies on Signal Transduction and Melanoma (In Partnership with the Melanoma Research Foundation)
Established in 2015 at the SMR congress in San Francisco, the Society for Melanoma Research in partnership with the Melanoma Research Foundation Congress established The Christopher J. Marshall Award For Studies on Signal Transduction and Melanoma. This award is presented to a student who has made substantial published and original contribution to studies of signal transduction and melanoma within the previous two years. The award’s focus on students, fellows or new PIs is in keeping with Chris Marshall’s dedication to mentoring and training new generations of cancer scientists.
2018 - Vito Rebecca, PhD
2016 - Maria Romina Girotti, PhD
The following awards are presented at the discretion of the Steering Committee for outstanding contributions by individuals or groups working closely with the Society for Melanoma Research in expanding education, sponsoring legislation and supporting the overall mission of SMR.
This award is given to an individual or group whose work has been at the forefront of skin cancer prevention.
2018 - Jeffrey E. Gershenwald, MD
2009 - Congresswoman Rosa L. DeLauro, CT
This award is presented to individuals or groups that have provided outstanding support to the Society for Melanoma Research in the delivery of the organization's mission.
2009 - Melanoma Research Foundation
accepted by Randy Lomax, President
This award is presented to individuals or groups that have done outstanding work in advocacy or education for the advancement in the fight for melanoma prevention and treatment.
2012 - California State Senator Ted W. Lieu, California Society of Dermatology & Dermatologic Surgery, and AIM at Melanoma Foundation
2011 - Connie Mack III, United States Senate, FL
2009 - Marty Tenenbaum, PhD, Founder and Chairman, Cancer Commons